| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |